Repository of National Pirogov Memorial Medical University, Vinnytsia

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

Files in this item

This item appears in the following Collection(s)

Search DSpace


My Account